Aripiprazole as an adjuvant treatment for obsessive and compulsive symptoms in bipolar disorder
Phase 3
Recruiting
- Conditions
- Bipolar disorder.Bipolar disorder
- Registration Number
- IRCT20230814059145N1
- Lead Sponsor
- Ahvaz University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 46
Inclusion Criteria
Age 18 to 60 years
Confirmation of bipolar disorder based on DSM-5 criteria
Exclusion Criteria
Not having cardiovascular, respiratory, kidney or digestive diseases
Not pregnant
Not suffering from drug or alcohol abuse
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Depression. Timepoint: Before the intervention and weeks 4, 8 and 12 after the intervention. Method of measurement: Hamilton.;Symptoms of mania. Timepoint: Before the intervention and weeks 4, 8 and 12 after the intervention. Method of measurement: Young mania rating scale.;Obsessive compulsive symptoms. Timepoint: Before the intervention and weeks 4, 8 and 12 after the intervention. Method of measurement: Yale brown obsessive compulsive scale scoring.
- Secondary Outcome Measures
Name Time Method Drug complication. Timepoint: Before the intervention and weeks 4, 8 and 12 after the intervention. Method of measurement: Abnormal Involuntary Movement scale.